{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:39:04Z","timestamp":1791909544498,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242300420071"],"award-info":[{"award-number":["242300420071"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701271"],"award-info":[{"award-number":["81701271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371304"],"award-info":[{"award-number":["82371304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.intimp.2025.115200","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:32:40Z","timestamp":1752607960000},"page":"115200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Autoimmune encephalitis with CASPR2 antibody: A case series and updated literature review"],"prefix":"10.1016","volume":"162","author":[{"given":"Xiaoke","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaokuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115200_bb0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115200_bb0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-n-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103118","article-title":"Rare antibody-mediated and seronegative autoimmune encephalitis: an update","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2025.115200_bb0030","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/ejn.14081","article-title":"Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases","volume":"48","author":"Saint-Martin","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2025.115200_bb0035","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"Lgi1, caspr2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2025.115200_bb0040","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2025.115200_bb0045","article-title":"Case report: prominent brainstem involvement in two patients with anti-caspr2 antibody-associated autoimmune encephalitis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115200_bb0050","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/jnnp-2020-323226","article-title":"Anti-caspr2 clinical phenotypes correlate with hla and immunological features","volume":"91","author":"Mu\u00f1iz-Castrillo","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2025.115200_bb0055","article-title":"Neuropathic pain and distinct caspr2 autoantibody igg subclasses drive neuronal hyperexcitability","author":"Habib","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.intimp.2025.115200_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577515","article-title":"Anti-contactin-associated protein-like 2 antibody-associated cerebellar ataxia: a case report and literature review","volume":"353","author":"Wang","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2025.115200_bb0065","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","article-title":"Systematic review of the clinical spectrum of caspr2 antibody syndrome","volume":"267","author":"Boyko","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.27177","article-title":"Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease","volume":"97","author":"Ceronie","year":"2025","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0080","doi-asserted-by":"crossref","first-page":"1213532","DOI":"10.3389\/fimmu.2023.1213532","article-title":"Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115200_bb0085","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/s41598-023-28268-x","article-title":"Caspr2 antibody associated neurological syndromes in children","volume":"13","author":"Wu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.115200_bb0090","doi-asserted-by":"crossref","first-page":"1106214","DOI":"10.3389\/fnins.2023.1106214","article-title":"Clinical spectrum of contactin-associated protein 2 autoimmune encephalitis in children","volume":"17","author":"Hu","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2025.115200_bb0095","first-page":"11","article-title":"Brain metabolic alterations in seropositive autoimmune encephalitis: an (18)f-fdg pet study","author":"Bergeret","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2025.115200_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652864","article-title":"Clinical character of caspr2 autoimmune encephalitis: a multiple center retrospective study","volume":"12","author":"Qin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115200_bb0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.seizure.2024.08.010","article-title":"Electroencephalographic outcomes and predictors of epilepsy in autoimmune encephalitis","volume":"121","author":"Jha","year":"2024","journal-title":"Seizure"},{"key":"10.1016\/j.intimp.2025.115200_bb0110","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neurad.2023.05.001","article-title":"A novel classification model based on cerebral 18f-fdg uptake pattern facilitates the diagnosis of acute\/subacute seropositive autoimmune encephalitis","volume":"50","author":"Bai","year":"2023","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.intimp.2025.115200_bb0115","first-page":"10","article-title":"Mesiotemporal volumetry, cortical thickness, and neuropsychological deficits in the long-term course of limbic encephalitis","author":"Harms","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.intimp.2025.115200_bb0120","doi-asserted-by":"crossref","first-page":"1140872","DOI":"10.3389\/fimmu.2023.1140872","article-title":"Clinical analysis of 173 pediatric patients with antibody-mediated autoimmune diseases of the central nervous system: a single-center cohort study","volume":"14","author":"Kang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115200_bb0125","first-page":"386","article-title":"Clinical features of 28 cases of anti-leucine-rich glioma-inactivated protein 1 encephalitis and anti-contactin-associated protein-like 2 encephalitis","volume":"48","author":"Feng","year":"2023","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.intimp.2025.115200_bb0130","doi-asserted-by":"crossref","first-page":"1256480","DOI":"10.3389\/fimmu.2023.1256480","article-title":"Brazilian autoimmune encephalitis network (brain): antibody profile and clinical characteristics from a multicenter study","volume":"14","author":"de Freitas","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115200_bb0135","first-page":"10","article-title":"Early-stage contactin-associated protein-like 2 limbic encephalitis: clues for diagnosis","author":"Benoit","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.intimp.2025.115200_bb0140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/epi.17164","article-title":"Caspr2-igg-associated autoimmune seizures","volume":"63","author":"Garrido Sanabria","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2025.115200_bb0145","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1111\/epi.17338","article-title":"Seizure underreporting in lgi1 and caspr2 antibody encephalitis","volume":"63","author":"Baumgartner","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2025.115200_bb0150","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211073203","article-title":"Clinical characteristics, long-term functional outcomes and relapse of anti-lgi1\/caspr2 encephalitis: a prospective cohort study in western China","volume":"15","author":"Guo","year":"2022","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.intimp.2025.115200_bb0155","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4103\/aian.aian_645_22","article-title":"Fdg-pet in autoimmune encephalitis: utility, pattern of abnormalities, and correlation with autoantibodies","volume":"25","author":"Jha","year":"2022","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jocn.2022.05.007","article-title":"Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a chinese cohort","volume":"101","author":"Li","year":"2022","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.intimp.2025.115200_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.736035","article-title":"Clinical features and outcomes in pediatric autoimmune encephalitis associated with caspr2 antibody","volume":"9","author":"Tan","year":"2021","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.intimp.2025.115200_bb0170","first-page":"8","article-title":"Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the generate registry","author":"Thaler","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.intimp.2025.115200_bb0175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/aian.AIAN_574_20","article-title":"Clinical profile and treatment response in patients with caspr2 antibody-associated neurological disease","volume":"24","author":"Shivaram","year":"2021","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.611597","article-title":"Clinical characteristics and outcome of neuronal surface antibody-mediated autoimmune encephalitis patients in a national cohort","volume":"12","author":"Hayden","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.607773","article-title":"An australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapy","volume":"12","author":"Swayne","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0190","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 lgi1\/caspr2-igg-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0200","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0210","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/WCO.0000000000000444","article-title":"Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies)","volume":"30","author":"Bastiaansen","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0215","first-page":"13","article-title":"Autoimmune encephalitis with antibodies: anti-nmdar, anti-ampar, anti-gq1b, anti-dppx, anti-caspr2, anti-lgi1, anti-ri, anti-yo, anti-hu, anti-cv2 and anti-gabaar, in the course of psychoses, neoplastic diseases, and paraneoplastic syndromes","author":"Braczkowski","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.intimp.2025.115200_bb0220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00415-019-09585-6","article-title":"Daratumumab treatment for therapy-refractory anti-caspr2 encephalitis","volume":"267","author":"Scheibe","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.intimp.2025.115200_bb0225","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct hla associations of lgi1 and caspr2-antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2025.115200_bb0230","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2311049121","article-title":"Ultrahigh frequencies of peripherally matured lgi1- and caspr2-reactive b cells characterize the cerebrospinal fluid in autoimmune encephalitis","volume":"121","author":"Theorell","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.intimp.2025.115200_bb0235","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbi.2024.08.027","article-title":"Human cerebrospinal fluid monoclonal caspr2 autoantibodies induce changes in electrophysiology, functional mri, and behavior in rodent models","volume":"122","author":"van Hoof","year":"2024","journal-title":"Brain Behav. Immun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:19:37Z","timestamp":1786159177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925011907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":47,"alternative-id":["S1567576925011907"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115200","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune encephalitis with CASPR2 antibody: A case series and updated literature review","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115200"}}